NM-ADTRAN
28.2.2024 14:01:33 CET | Business Wire | Press release
Adtran today announced that Mescalero Apache Telecom, Inc. (MATI) is harnessing its fiber access solution to bring high-speed connectivity to rural tribal communities in New Mexico. Supported by a mix of loans and grant funds, MATI’s new infrastructure is the first full FTTH XGS-PON network to be built among any tribal nation. Part of the Broadband Infrastructure Deployment initiative, the solution will deliver symmetrical Gigabit services to the Mescalero Apache reservation. The deployment is set to have a significant impact on the community, empowering residents with access to critical online resources such as education, telehealth services and remote work opportunities. Key components of the new network include Adtran’s AI-driven Mosaic One Device Manager and its Oscilloquartz timing and synchronization technology. Adtran’s partner, Netceed, a leading provider of materials, distribution and supply chain management solutions supporting the telecommunications and broadband industry, is also playing a key role in the project.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240228081531/en/
Mescalero Apache Telecom, Inc. is using Adtran’s technology to deliver high-speed broadband services to tribal communities in New Mexico. (Photo: Business Wire)
“Building high-quality internet infrastructure is one of the most effective ways of improving life in tribal communities. That’s why, as part of the award we’ve received to help close the digital divide in New Mexico, we’re connecting 29 community anchor institutions, including libraries and Head Start centers, to our new symmetrical Gigabit services,” said Godfrey Enjady, GM of MATI. “As our trusted and longstanding partner, it’s great to have Adtran by our side as we roll out the first FTTH tribal network using XGS-PON technology. By leveraging their innovation, we’re expanding and enhancing our network with a flexible, scalable platform primed to address today’s connectivity challenges and ready to support tomorrow’s multigigabit demands.”
Adtran’s technology is empowering MATI to seamlessly transition to an XGS-PON network that provides full-fiber and fixed wireless access connectivity. The Total Access 5000 lays the foundations for a robust infrastructure, while Mosaic One streamlines network operations and subscriber device management for efficient, customer-centric service delivery. Adtran’s ONTs are supplying high-speed internet to 835 previously unserved households and 336 business premises. Featuring a 10GbE interface, the compact and powerful devices are also capable of providing premium multigigabit services. For enhanced in-home coverage, Adtran’s high-performance mesh routers deliver extensive and reliable connectivity. And with the precision of Adtran’s Oscilloquartz synchronization technology, the solution ensures a seamless and robust experience for new and existing subscribers.
“We’re proud to support MATI in its mission. What we all share is a commitment to fostering digital inclusivity. It’s crucial that tribal communities are not just connected but also fully equipped with the reliable, high-quality tools and resources necessary to thrive in an increasingly digital world,” commented John Scherzinger, GM of Americas sales at Adtran. “By leveraging our broadband solutions and the dedicated support of the Adtran and Netceed team, MATI is enriching lives and creating new opportunities for learning, growth and development. It’s enabling these previously underserved communities to make digital access a foundational element of their growth and success.”
“At Netceed, a large part of our mission involves connecting the unconnected. As a one-stop shop distribution and solutions partner to our customers, we strive to push the boundaries of technology, helping ensure universal access to digital opportunities,” noted Chet Enos, senior director of sales, south central at Netceed. “The deployment of Adtran’s open and scalable fiber access solution marks a significant advancement for these communities. Working closely together, we’ve been able to equip MATI’s subscribers with the high-quality, ultra-fast broadband they deserve. It’s vital that New Mexico’s rural tribal homes and businesses have affordable access to the same information and resources available in other areas of the country. With its new network, MATI is paving the way for people living in remote regions to benefit from a more connected and prosperous future, and we’re proud to be part of this initiative.”
Further information on how Adtran is helping MATI and its communities is available in this video.
About Adtran
ADTRAN Holdings, Inc. (NASDAQ: ADTN and FSE: QH9) is the parent company of Adtran, Inc., a leading global provider of open, disaggregated networking and communications solutions that enable voice, data, video and internet communications across any network infrastructure. From the cloud edge to the subscriber edge, Adtran empowers communications service providers around the world to manage and scale services that connect people, places and things. Adtran solutions are used by service providers, private enterprises, government organizations and millions of individual users worldwide. ADTRAN Holdings, Inc. is also the largest shareholder of Adtran Networks SE, formerly ADVA Optical Networking SE. Find more at Adtran, LinkedIn and X.
Published by
ADTRAN Holdings, Inc.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240228081531/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Bending Spoons S.p.A. announces pricing of initial public offering1.7.2026 01:56:00 CEST | Press release
Bending Spoons S.p.A. (“Bending Spoons”), a leading technology company, today announces the pricing of its initial public offering (“IPO”) at $29.00 per share. A total of 57,971,015 ordinary shares are being offered, of which 34,398,640 shares are being offered by Bending Spoons and 23,572,375 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Bending Spoons will not receive any proceeds from any sale of shares by the Selling Shareholders. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “BSP” on July 1, 2026. The offering is expected to close on July 2, 2026, subject to customary closing conditions. In addition, Bending Spoons and the Selling Shareholders granted the underwriters an option to purchase up to an additional 5,244,026 ordinary shares from Bending Spoons and up to an additional 3,451,626 ordinary shares from the Selling Shareholders at the initial public offering price, less underwriting
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release
In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 16:08:00 CEST | Press release
Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom